Drug Profile
UIO 702
Alternative Names: UIO-702Latest Information Update: 28 Mar 2022
Price :
$50
*
At a glance
- Originator Unleash Immuno Oncolytics
- Class Antineoplastics; Viruses
- Mechanism of Action Apoptosis stimulants; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer